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We present three patients with Wolf-
Hirschhorn syndrome with small cyto-
genetic deletions of 4pl6. One case is a de
novo translocation and two cases repres-
ent de novo deletions. Using molecular
techniques we determined the extent of
these deletions and attempted to ascer-
tain parental origin. Case 1 had a deletion
of 4pl6.3 with a breakpoint proximal to
D4S1O, case 2 had a larger deletion
including D4S62 in 4pl6.2, and case 3 had
the largest deletion which included
D4S240, but not the Raf2 locus in 4pl6.1.
The parental origin of the deletion in case
3 was paternal; the other two cases were
indeterminable. Our results show that
these three deletions include the cur-
rently proposed Wolf-Hirschhorn syn-
drome critical region within the most
distal 2 Mb of 4pl6.3 and offer supportive
evidence for continuous terminal dele-
tions.
(J Med Genet 1994;31:103-107)
The Wolf-Hirschhorn syndrome (WHS) has
an incidence of 1/50 000 live births and is
characterised by severe pre- and postnatal
growth retardation, severe mental retardation,
distinct facial features (fig 1), and a number of
other anomalies (table 1).'2 WHS is associated
with a deletion of the short arm of chromo-
some 4 which can occur as a result of a terminal
or interstitial deletion, a translocation, or a
ring chromosome 4.3 Although previously
observed deletions have varied in size, the
common region responsible for WHS appears
to fall in 4pl6.'34
Previous clinical reports comparing
patients' deletions and phenotypes suggest a
lack of correlation between the size of the
deletion and the clinical severity.'5 A dif-
ference in the prevalence of the parental origin
of the de novo deleted chromosome was also
observed; 17 cases of paternally derived 4p
deletions and two maternally derived 4p dele-
tions have been reported.6-3 These observa-
tions led to initial speculations of an imprint-
ing role in WHS.'3 The lack of correlation
between deletion size and clinical severity can-
not be attributed to imprinting, however, since
most patients have deletions from the same
parental origin (paternal). Other influences
including environmental factors, differences in
genetic constitution, or a masking of features
by the effects of other deleted genes could
contribute to this lack of correlation. The
observation of predominantly paternally de-
rived deletions can not be completely
explained by imprinting either since the
patients with maternally derived de novo dele-
tions or those who have inherited a derivative
chromosome 4 from a maternal translocation
carrier have classic WHS and are not consis-
tently more severely affected than the patients
with paternally derived deletions.9'' 14-16 The
preponderance of paternal origin of the de
novo deletions probably reflects differences in
the exposure and susceptibility of male and
female germ cells to chromosomal damage
which leads to deletion formation.7
Many of the previously described WHS
deletions were cytogenetically large, including
regions of 4p proximal to 4pl6.4 We present
three WHS patients with small cytogenetic
deletions. Using molecular techniques we have
defined the extent of these deletions,
attempted to determine their parental origins,
and investigated a correlation between the size
of the deletion and the clinical phenotype.
Materials and methods
CASE REPORTS
Case 1. This young girl was the 1900 g prod-
uct of a 38 week pregnancy complicated by
poor weight gain and toxaemia (fig 1). A pos-
terior cleft palate was noted at birth and birth
weight, length, and head circumference were
all below the 3rd centile. The patient began
walking at the age of 3 years. At 4 years she
experienced a generalised seizure. A karyotype
at the age of 6 years showed a deletion of
chromosome 4 secondary to a de novo un-
balanced translocation. At 17 years her height,
weight, and head circumference were below
the 5th centile; she was unable to speak and
remained incontinent. Her clinical features are
summarised in table 1.
Case 2. This male infant was the 1530 g
product of a 36 week pregnancy complicated
by maternal toxaemia and delivery by caesar-
ian section (fig 1). In view of the patient's
malformations (table 1) and small size, he was
admitted to the neonatal intensive care unit.
Blood karyotypes showed a 4p deletion. At 21
months of age he continued to experience
failure to thrive, with height, weight, and head
circumference still below the 5th centile. Al-
though his vocalisation increased after he
received a hearing aid, he is still unable to
communicate verbally.
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Figure I Pictures of three patients with WHS. The picture of case 1 (A) was take
at 13 years of age, case 2 (B) was 13 months old, and case 3 (C) was 11 years old.
Case 1 has a deletion of chromosome 4 secondary to a translocation resulting in
monosomy 4p and trisomy for another unidentified chromosomal segment. Her facial
features presumably reflect the effects of both monosomy and trisomy.
Case 3. This female was the 2100 g product
of a caesarian section delivery because of non-
progression of labour (fig 1). She was cyanotic
at delivery requiring a ventilator for one day
and admission to hospital for two to three
weeks. Seizures began at the age of 6 months.
At 11 years the patient remained well below
the 5th centile for height, weight, and head
circumference. The patient can walk with as-
sistance and is able to speak a few words. Her
clinical features are listed in table 1. Although
clinical evaluation suggested WHS, her 4p
deletion was not detected by cytogenetic
3.. analysis until the age of 10 years.
CYTOGENETIC ANALYSIS
Standard cytogenetic methods were used to
produce high resolution G banded cytogenetic
preparations from short term lymphocyte cul-
tures.'7 Ethidium bromide was added to the
cultures 90 minutes before harvest to enhance
chromosome length. Silver staining (AgNOR)
was also done on case 1 in order to rule out
involvement of an acrocentric short arm in the
de novo translocation.'7
PREPARATION OF GENOMIC DNA AND PROBES
Genomic DNA was obtained from EBV trans-
formed lymphoblastoid cell lines from the
patients and their parents according to pre-
viously described techniques.'8 Interested
researchers can obtain these cell lines by con-
tacting Dr Estabrooks or Dr Rao. Probes used
in the Southern blot analyses (table 2) and
fluorescence in situ hybridisation (FISH) were
also prepared according to previously de-
scribed techniques.'8
SOUTHERN BLOTS
Southern blot analyses using several chromo-
some 4p16 probes and their respective restric-
tion enzymes (table 2) were performed as de-
scribed previously.'8 Autoradiograph signals
Table I Anomalies observed in the three patients with WHS are listed. The frequency with which the individual
clinical features have been observed irn previously reported WHS patients are also listed
Case 1 Case 2 Case 3 Review* (%)
Growth retardation
Fetal + + + 89
Postnatal + + + 76
Mental retardation + + +
100
Microcephaly + + +
91
Prominent glabella + + + 47
Broad, beak-like nose + + +
64
Hypertelorism + + + 74
Large, simple ears - (Small) + + 69
Micrognathia - (Prognathism) + + 69
Cleft palate + + (+ CL) - 57
Renal abn + ? + UNK
Strabismus + + -
36
Genital abn + + -
64
CHD (ASD) - + +
55
Downward slanting palpebral fissures - + +
Bilteral dacryostenosis + + +
Seizures + + 47
Contractures +
Ptosis + - -
28
Hearing loss - +
Sacral dimple - + -
33
Hypotonia - - +
Fused teeth - - +
Nystagmus - - +
Skeletal abn (scoliosis) - - + 66
Epicanthic folds - - +
26
* Review of 43 WHS patients.
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Table 2 The results of qualitative and quantitative Southern blot analysis are given. The probe and restriction
enzyme used for each locus are listed with each patient's result for the probe and the method by which the result was
determined"
Case 1 Case 2 Case 3
Restriction
Locus Probe enzyme Status (Method) Status (Method) Status (Method)
D4S141 2R3 HindIII del (D) del (D) del (R)
D4SI 15 252-3 PstI del (D) del (D) del (D)
D4S95 674 PstI del (D) del (D) del (D)
D4S1O pCos5.52 PstI del (D) del (D) del (R)
D4S62 p8 PstI not del (D) del (D) del (D)
D4S240 pTV73 PstI not del (D) not del (D) del (D)
D4S241 pTV45 PstI not del (D) not del (D) not del (D)
Raf2 Raf2 MspI not del (D) not del (D) not del (D)
del = deleted. (D) = densitometry. (R) = RFLP analysis.
were interpreted using restriction fragment
length polymorphisms (RFLPs) or densito-
metry readings from a Shimadzu scanning
densitometer. The chromosome 7 probe
KM19 was used as a control probe for densito-









Figure 2 Examples of qualitative and
quantitative Southern blot analysis. (A) A
paternal deletion of pCos5.52 (D4S10) in case 3 252-3
detected with a restriction fragment length
polymorphism using the restriction enzyme PstI.
(B) A deletion of p252-3 (D4S115) in case 2 21
detected with quantitative Southern blot analysis.
The DNA is cut with PstI, and the chromosome 7
probe KM1 9 is used to correct for differences in DNA amounts between lanes. The
ratio of the corrected p252-3 signal reading between the mother and the proband is 2 0
to 1, indicating a deletion of p252-3 in the proband.
A B
FLUORESCENCE IN SITU HYBRIDISATION
The acrocentric I satellite probe and chromo-
some 4 centromeric a satellite probe (D4Z1)
labelled with biotin were obtained from Oncor
(Gaithersburg, MD). Biotin labelled chromo-
some paint probes (chromosomes 1, 2, 3, 4, 6,
8, and 12) were acquired from Imagenetics
(Naperville, IL). The pC847.35 1 cosmid
probe was provided by Dr Altherr and Dr
Wasmuth at UC Irvine. The acrocentric ,B
satellite probe is known to hybridise to I
satellite sequences in the cytological satellites
and to sequences in the proximal short arm of
acrocentric chromosomes; D4Z1 hybridises to
alphoid repeats found at the chromosome 4
centromere; and the chromosome paint probes
hybridise to unique sequences located
throughout the length of the respective chro-
mosome. The pC847.351 probe is a 38 kb
cosmid probe which is part of the D4S26 locus
and maps 150 kb from the p terminus of chro-
mosome 4.16
Fluorescence in situ hybridisation was per-
formed according to protocols provided by
Oncor (Gaithersburg, MD) and Imagenetics
(Naperville, IL). Slides hybridised with the
pC847.35 1 cosmid probe received an addi-
tional round of amplification (for a total of two)
in order to maximise the signal. Sequential
analysis was achieved by initially staining
slides for classical cytogenetic analysis, de-
staining the slides with a 10 minute ethanol
exposure followed by two 10 minute methanol
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Figure 3 Examples of the deleted chromosome 4. (A) Chromosome 4 ideo,
band level, ISCN 198520) depicts the cytogenetic breakpoints in the three I
patients. (B) Partial karyotypes of chromosome 4 from each case. The dele




Case 1 appears to have a deletion of chromo-
some 4p16.3-pter secondary to a translocation
that has remained indecipherable with current
cytogenetic staining techniques (fig 3). The
5; AgNOR staining results regarding B group
gg chromosomes were negative, although this
C'
technique could not rule out the presence
of an inactive NOR. Her karyotype is
46,XX, -4, + der(4)t(4;?) (p1 6.3;?) de novo.
Case 2 has an apparently terminal deletion
of chromosome 4 (fig 3). A trace of G band
positive material at the tip of the deleted chro-
mosome and the lack of 4p 16.3 suggest a
breakpoint at 4p16.2: 46,XY,del(4) (p16.2).
gram (850 Parental karyotypes were normal.
eted Case 3 also has an apparently terminal dele-
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Figure 4 Examples of FISH. (A) A metaphase spread of a normal control showing
the hybridisation of the pC847.351 cosmid probe to both chromosome 4 short arms
(arrows). (B) A metaphase spread of one of the apparently terminal deletion patients
(case 3) showing hybridisation of the pC847.351 cosmid probe to only one chromosome
4 short arm (arrows). A chromosome 4 centromere probe (D4Z1) was usedfor
identification.
bands 4pl6.2 and 4pi6.3 (fig 3). Her karyotype
designation is 46,XX,del(4) (p16.1). Parental
karyotypes were normal.
FISH ANALYSIS
All three WHS cases failed to show hybridisa-
tion on one chromosome 4 with the cosmid
probe pC847.351, a distal 4p probe (fig 4).
Sequential banding (G banding followed by
FISH) showed that pC847.351 was consist-
ently missing from the deleted chromosome 4
in 12/12, 14/14, and 1 1/11 metaphases ex-
amined in case 1, case 2, and case 3 respect-
ively. Cosmid probe signals were observed on
the normal homologue in each of these meta-
phases. Metaphases with no cosmid signal
were disregarded since they were uninform-
ative. These observations are statistically sig-
nificant (p<000001) using a one tailed t test
and indicate that these deletions extend to at
least 150 kb from the 4p terminus.
The second chromosome involved in the
translocation in case 1 remained unidentified
despite FISH with whole chromosome specific
paint probes to chromosomes 1, 2, 3, 4, 6, 8,
and 12 (data not shown). D satellite and Y long
arm probes excluded the involvement of an
acrocentric short arm or the Y chromosome
long arm (data not shown).
SOUTHERN BLOTTING
The extent of each patient's 4p deletion is
illustrated in fig 5. In case 1, the deletion
involved approximately 6Mb, in case 2 ap-
proximately 8 Mb, and in case 3 greater than
8 Mb of the distal 4pl6 region, based on a
current physical map of chromosome 4p16.2'
Only case 3 provided parental origin informa-











Case 1 deletion 6 Mb
Case 2 deletion 8 Mb
Case 3 deletion > 8 Mb
Figure 5 Map of WHS deletions. A diagram depicts the three WHS deletio
relation to each other, to the currently proposed WHS critical region,'82' and
approximate position of the most distal loci.20 Probes pTV45 (D4S241) and I
(D4S40) have been mapped to chromosome 4p16 proximal to D4S62 by soma
hybrid analysis (Carlock, unpublished observations). The cosmid probe pC84;
designated as (351), maps approximately 150 kb from 4pter, and does not apl
in the Wolf-Hirschhorn syndronme critical region.'6 18
Discussion
We have defined the molecular extent of chro-
mosome 4p deletions in three WHS patients.
There was excellent correlation between the
molecularly determined breakpoints and those
estimated in the original cytogenetic diagnosis
(fig 5). This. correlation substantiates the pre-
cision of high resolution cytogenetic analysis.
Although the proximal breakpoints of our
three patients' deletions differed, they all
- 4p tel shared a common deleted region. This region
is defined by the smallest deletion, seen in case
1, which falls in 4pl6.3 from D4S10 to the 4p
terminus (fig 5). This smallest region of over-
)n lap among our patients consists of the distal
6 Mb of 4p16.3, based on 4p physical mapping
data.2'
Although these deletions are cytogenetically
small, they are not the smallest reported dele-
tions in WHS patients. Recently a WHS
wns in patient with a terminal deletion of the distal
to the 2 Mb of chromosome 4p was reported, placing
pTV73 the WHS critical region in the distal third of
7tic5sell 4p16.3.22 A previously published report placed
pear to be the WHS critical region distal to D4S10.9 All
of our deletions include the D4S10 locus and
106
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the currently purported WHS critical region
within the distal 2 Mb of 4pl6.3 (fig 5).
We recently reported two families with a
satellited chromosome 4 resulting in a deletion
detected by probes pC847.351 and B31 with
no family history of WHS.'8 Another report
describes an affected subject inconsistent with
the classic WHS phenotype who had a distal
4p deletion and partial 7q trisomy secondary
an inherited translocation.22 These cases
further define the WHS critical region
proximal to the most distal 150 kb.
The deletion of the pC847.351 cosmid probe
in the two apparently terminal deletion
patients (cases 2 and 3) is consistent with
continuous, terminal deletion since pC847.351
maps only 150 kb from the 4p telomere,'6 but
this observation can not disprove an interstitial
deletion with a second breakpoint less than
150 kb from the telomere. Investigations with
the pC847.351 probe in two additional WHS
patients have also shown a deletion of this
distal region offering further supportive evid-
ence for terminal deletions.23
mere probes on these two patients confirmed
the presence of telomere sequences on the
deleted 4p ends (Roulston, personal commun-
ication). This suggests that, if terminal, these
deletions may have been healed by the addition
of telomere sequences on the broken ends,
presumably by telomerase.245
Our phenotypic data also appear to support
previous observations of a lack of correlation
between deletion size and clinical severity
(table 1). The three patients do, however,
manifest various shared and unique clinical
features. Some of the unique features observed
in case may be attributable to the partial
trisomy resulting from her de novo rearrange-
ment. Those features that do not always
correlate with overlapping, mutually deleted
regions may result from deletions of chromo-
some 4p gene(s) that are sensitive to influences
by environmental, stochastic, or additional
genetic factors. The lack of substantial
crease in the clinical severity and
number of specific clinical features observed
patients with larger deletions may also reflect
the actual number of genes in the additionally
deleted region. Ultimately, identification
the genes normally residing in4pl6 should
offer some explanations for these observations.
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